Search Result "sorafenib."


Research Article

Sorafenib as a Salvage Therapy in FLT3-ITD Negative Relapse/Refractory Acute Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 1489-1494
Author(s): Nan Yang,Zhenyang Gu,Zhanxiang Liu,Wenrong Huang,Shuhong Wang,Lili Wang,Chunji Gao

General Research Article

Dantrolene Potentiates the Antineoplastic Effect of Sorafenib in Hepatocellular Carcinoma via Targeting Ca+2/PI3K Signaling Pathway

Journal: Current Molecular Pharmacology
Volume: 14 Issue: 0 Year: 2021 Page: 1-14
Author(s): Sherin Zakaria,Abeer Ansary,Nabil M. Abdel-Hamid,Mamdouh M. ElShishtawy

Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 7 Year: 2012 Page: 938-944
Author(s): G. Ranieri, G. Gadaleta-Caldarola, V. Goffredo, R. Patruno, A. Mangia, A. Rizzo, R. L. Sciorsci, C. D. Gadaleta

Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 8 Year: 2011 Page: 944-953
Author(s): H. Huynh, S. P. Choo, H. C. Toh, W. M. Tai, A. Y.F. Chung, P. K.H. Chow, R. Ong, K. C. Soo

Research Article

Self Nanoemulsifying Drug Delivery System of Sorafenib Tosylate: Development and In Vivo Studies

Journal: Pharmaceutical Nanotechnology
Volume: 8 Issue: 6 Year: 2020 Page: 471-484
Author(s): Pamu Sandhya,Pamu Poornima,Darna V.R.N. Bhikshapathi

Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib

Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 15 Year: 2012 Page: 1649-1659
Author(s): Lale Erdem,Elisa Giovannetti,Leticia G Leon,Richard Honeywell,Godefridus J. Peters

Development of Sorafenib in Malignant Gliomas: Rationale and Early Clinical Experience

Ebook: Young People’s Visions of the World

Volume: 1 Year: 2010
Author(s): Rachel Grossman, Jaishri Blakeley
Doi: 10.2174/97816080513281100101

Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 927-939
Author(s): E. Giovannetti,M. Labots,H. Dekker,E. Galvani,J.S.W. Lind,R. Sciarrillo,R. Honeywell,E.F. Smit,H.M. Verheul,G.J. Peters

Research Article

Synthesis, Biological Evaluation and Docking Studies of Sorafenib Derivatives N-(3-fluoro-4-(pyridin-4-yloxy)phenyl)-4(5)-phenylpicolinamides

Journal: Medicinal Chemistry
Volume: 13 Issue: 2 Year: 2017 Page: 176-185
Author(s): Min Wang,Chunjiang Wu,Shan Xu,Yan Zhu,Wei Li,Pengwu Zheng,Wufu Zhu

In Vitro and In Vivo Antitumor Efficacy of Docetaxel and Sorafenib Combination in Human Pancreatic Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 10 Issue: 6 Year: 2010 Page: 600-610
Author(s): P. Ulivi, C. Arienti, W. Zoli, M. Scarsella, S. Carloni, F. Fabbri, A. Tesei, E. Chiadini, A. Orlandi, D. Passeri, G. Zupi, C. Milandri, R. Silvestrini, D. Amadori, C. Leonetti

Previous   Next

Go To   Results 11 - 20 of 1209

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy